In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection.

Documenti analoghi

• Voriconazole (UK-109,496) inhibits the growth and alters the morphology of fluconazole-susceptible and -resistant Candida species.
  di: Belanger, P, et al.
  Pubblicazione: (1997)
• A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
  di: Sanati, H, et al.
  Pubblicazione: (1997)
• In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species.
  di: Barry, A L, et al.
  Pubblicazione: (1996)
• In Vitro Activities of Voriconazole (UK-109,496) and Four Other Antifungal Agents against 394 Clinical Isolates of Candida spp.
  di: Marco, F., et al.
  Pubblicazione: (1998)
• Comparative evaluation of three antifungal susceptibility test methods for Candida albicans isolates and correlation with response to fluconazole therapy.
  di: Ruhnke, M, et al.
  Pubblicazione: (1996)